Mwanzo300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Bei iliyotangulia
¥ 13.54
Bei za siku
¥ 13.54 - ¥ 13.76
Bei za mwaka
¥ 12.93 - ¥ 23.45
Thamani ya kampuni katika soko
15.20B CNY
Wastani wa hisa zilizouzwa
13.43M
Uwiano wa bei na mapato
100.69
Mgao wa faida
-
Ubadilishanaji wa msingi
SHE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 645.20M | 42.85% |
Matumizi ya uendeshaji wa biashara | 424.14M | 38.76% |
Mapato halisi | 22.43M | -58.51% |
Kiwango cha faida halisi | 3.48 | -70.93% |
Mapato kwa kila hisa | — | — |
EBITDA | 127.47M | 2.48% |
Asilimia ya kodi ya mapato | 17.00% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 219.94M | -77.94% |
Jumla ya mali | 14.25B | -5.10% |
Jumla ya dhima | 4.57B | -15.33% |
Jumla ya hisa | 9.68B | — |
hisa zilizosalia | 1.12B | — |
Uwiano wa bei na thamani | 1.56 | — |
Faida inayotokana na mali | 0.86% | — |
Faida inayotokana mtaji | 1.07% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 22.43M | -58.51% |
Pesa kutokana na shughuli | -46.30M | 39.22% |
Pesa kutokana na uwekezaji | -65.23M | 82.73% |
Pesa kutokana na ufadhili | -98.94M | -180.59% |
Mabadiliko halisi ya pesa taslimu | -210.53M | 36.40% |
Mtiririko huru wa pesa | -2.72B | -245.41% |
Kuhusu
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Ilianzishwa
8 Sep 1992
Tovuti
Wafanyakazi
1,913
